Akira Honda, Yasutaka Masuda, Yu Oyama, Kensuke Matsuda, Hideaki Mizuno, Akiko M Saito, Yoshio Katayama, Norio Komatsu, Kazuhiro Toyama, Mineo Kurokawa. Prognostic factors of idiopathic hypereosinophilic syndrome: A nationwide survey in Japan. British journal of haematology. 2024
Tatsuya Konishi, Kensuke Matsuda, Hidehiro Itonaga, Noriko Doki, Tetsuya Nishida, Ken-Ichi Matsuoka, Takashi Ikeda, Yoshinobu Kanda, Takahiro Fukuda, Junya Kanda, et al. Impact of Early Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation on Relapse in Patients with Myelodysplastic Syndrome: A Nationwide Retrospective Study from Adult Myelodysplastic Syndrome Working Group of the JSTCT. Transplantation and cellular therapy. 2024
Kensuke Matsuda, Sumimasa Nagai, Koichi Sugimoto. Drug approval delays in hematologic malignancies between Europe and the US and between Japan and the US: a clinical perspective. Japanese journal of clinical oncology. 2023. 53. 12. 1125-1129
Masamitsu Yanada, Yoshimitsu Shimomura, Shohei Mizuno, Kensuke Matsuda, Tadakazu Kondo, Noriko Doki, Masatsugu Tanaka, Takahiro Fukuda, Takahide Ara, Naoyuki Uchida, et al. External validation and extended application of the transplant conditioning intensity score in acute myeloid leukemia. Bone marrow transplantation. 2023. 58. 10. 1096-1103
Yoshitomo Hoshino, Katsunori Manaka, Junichiro Sato, Yui Asatsuma, Hirofumi Horikoshi, Maki Takeuchi, Nobuaki Ito, Megumi Fujita, Megumi Yasunaga, Kensuke Matsuda, et al. Recurrent bilateral adrenal infarction with myelodysplastic/myeloproliferative neoplasm-unclassifiable (MDS/MPN-U): a case report. BMC endocrine disorders. 2023. 23. 1. 128-128
松田 健佑, 永井 純正, 杉本 耕一. 血液領域における日米間のドラッグラグの疾患別解析(Disease-Specific Analysis of the Drug Lag between the U.S. and Japan in Hematological Malignancies). 日本癌学会総会記事. 2022. 81回. P-3384
吉田 澪奈, 松田 健佑, 千葉 晶輝, 牧 宏彰, 本田 晃, 正本 庸介, 常名 政弘, 西川 真子, 矢冨 裕, 黒川 峰夫. 多発性骨髄腫に対する自家移植後の大顆粒リンパ球出現の特徴と予後への影響(Expansion of Large granular lymphocytes after autologous hematopoietic stem cell transplantation for multiple myeloma). International Journal of Myeloma. 2022. 12. 3. 161-161